Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 19, 2018 - Issue 18
Submit an article Journal homepage
695
Views
22
CrossRef citations to date
0
Altmetric
Review

Afatinib and Erlotinib in the treatment of squamous-cell lung cancer

Marco TagliamentoLung Cancer Unit, Ospedale Policlinico San Martino, Genoa, ItalyORCID Iconhttps://orcid.org/0000-0001-7461-023XView further author information
ORCID Icon,
Carlo GenovaLung Cancer Unit, Ospedale Policlinico San Martino, Genoa, Italy;Department of Internal Medicine and Medical Specialties (DIMI), University of Genoa, Genoa, ItalyORCID Iconhttps://orcid.org/0000-0003-3690-8582View further author information
ORCID Icon,
Erika RijavecLung Cancer Unit, Ospedale Policlinico San Martino, Genoa, ItalyView further author information
,
Giovanni RossiLung Cancer Unit, Ospedale Policlinico San Martino, Genoa, ItalyView further author information
,
Federica BielloLung Cancer Unit, Ospedale Policlinico San Martino, Genoa, ItalyView further author information
,
Maria Giovanna Dal BelloLung Cancer Unit, Ospedale Policlinico San Martino, Genoa, ItalyView further author information
,
Angela AlamaLung Cancer Unit, Ospedale Policlinico San Martino, Genoa, ItalyView further author information
,
Simona CocoLung Cancer Unit, Ospedale Policlinico San Martino, Genoa, ItalyView further author information
,
Simona BoccardoLung Cancer Unit, Ospedale Policlinico San Martino, Genoa, ItalyView further author information
&
Francesco GrossiFondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Medical Oncology, Milan, ItalyCorrespondence[email protected]
View further author information
 show all
Pages 2055-2062 | Received 22 Jun 2018, Accepted 16 Oct 2018, Published online: 03 Nov 2018

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Jianfang Fu, Jie Yu, Xiang Zhang, Yaoyao Chang, Hongze Fan, Mengzhen Dong, Mengjia Li, Yue Liu & Jinxing Hu. (2023) Design, synthesis, and biological evaluation of pyrido[2,3-d]pyrimidine and thieno[2,3-d]pyrimidine derivatives as novel EGFRL858R/T790M inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Xuejuan Gao, Junjie Zhu, Linsong Chen, Yan Jiang, Xiao Zhou, Jianwei Shuai & Yanfeng Zhao. (2019) Clinical And Imageological Features Of Lung Squamous Cell Carcinoma With EGFR Mutations. Cancer Management and Research 11, pages 9017-9024.
Read now

Articles from other publishers (20)

Jiatong Li, Ao Gu, Xiao‐Mei Nong, Shuyang Zhai, Zhu‐Ying Yue, Meng‐Yao Li & Yingbin Liu. (2023) Six‐membered Aromatic Nitrogen Heterocyclic Anti‐Tumor Agents: Synthesis and Applications. The Chemical Record.
Crossref
Li Gan, Qiyu Xiao, Yusong Zhou, Ying Fu & Mengjie Tang. (2023) Role of anoikis-related gene PLK1 in kidney renal papillary cell carcinoma: a bioinformatics analysis and preliminary verification on promoting proliferation and migration. Frontiers in Pharmacology 14.
Crossref
Kiran Jyoti, Garima Malik, Monika Chaudhary, Jitender Madan & Anjoo Kamboj. (2023) Hyaluronate decorated polyethylene glycol linked poly(lactide-co-glycolide) nanoparticles encapsulating MUC-1 peptide augmented mucosal immune response in Balb/c mice through inhalation route. Biochimica et Biophysica Acta (BBA) - General Subjects 1867:4, pages 130317.
Crossref
DONGYANG WANG, YI CHEN, JING HUANG, YOU ZHANG, CHONGKUI SUN & YINGQIANG SHEN. (2023) Glucocorticoid reduces the efficacy of afatinib on the head and neck squamous cell carcinoma. BIOCELL 47:2, pages 329-338.
Crossref
Dapeng Wang, Huifen Xu, Lili Fan, Wenli Ruan, Qian Song, Heng Diao, Rui He & Ying Jin. (2023) Hyperphosphorylation of EGFR/ERK signaling facilitates long-term arsenite-induced hepatocytes epithelial-mesenchymal transition and liver fibrosis in sprague-dawley rats. Ecotoxicology and Environmental Safety 249, pages 114386.
Crossref
Seamus Balinth, Matthew L. Fisher, Yon Hwangbo, Caizhi Wu, Carlos Ballon, Xueqin Sun & Alea A. Mills. (2022) EZH2 regulates a SETDB1/ΔNp63α axis via RUNX3 to drive a cancer stem cell phenotype in squamous cell carcinoma. Oncogene 41:35, pages 4130-4144.
Crossref
Binfeng Liu, Zhongyue Liu, Chengyao Feng & Chao Tu. (2022) A Necroptosis-Related lncRNA Signature Predicts Prognosis and Indicates the Immune Microenvironment in Soft Tissue Sarcomas. Frontiers in Genetics 13.
Crossref
Gulam Moin Shaikh, Manikanta Murahari, Shikha Thakur, Maushmi S. Kumar & Mayur YC. (2022) Studies on ligand-based pharmacophore modeling approach in identifying potent future EGFR inhibitors. Journal of Molecular Graphics and Modelling 112, pages 108114.
Crossref
Jianbing Hou, Minghao Xu, Hongyu Gu, Dakun Pei, Yudong Liu, Pan Huang, Hongbo Chang & Hongjuan Cui. (2022) ZC3H15 promotes glioblastoma progression through regulating EGFR stability. Cell Death & Disease 13:1.
Crossref
Shan Liu, Xiaocheng Huang, Jin Wen, Fangfang Fu & Huifen Wang. (2021) Application of Evidence-Based Nursing Intervention in the Treatment of Advanced Squamous Cell Carcinoma of the Lung by Erlotinib Combined with Tegafur, Gimeracil, and Oteracil Potassium and Its Influence on Quality of Life. Journal of Healthcare Engineering 2021, pages 1-6.
Crossref
A. Lőrincz, J. Mihály, A. Wacha, Cs. Németh, B. Besztercei, P. Gyulavári, Z. Varga, I. Peták & A. Bóta. (2021) Combination of multifunctional ursolic acid with kinase inhibitors for anti-cancer drug carrier vesicles. Materials Science and Engineering: C 131, pages 112481.
Crossref
Yiping Zhu, Liwei Shen & Yaozheng Zhou. (2021) Nano-Particulated Erlotinib Compound System in Alleviation of Lung Cancer. Journal of Biomedical Nanotechnology 17:10, pages 1984-1992.
Crossref
Gang Qiao, Hai-Bo Wang, Xiu-Na Duan & Xiao-Fang Yan. (2021) The effect and mechanism of miR-607/CANT1 axis in lung squamous carcinoma. Anti-Cancer Drugs 32:7, pages 693-702.
Crossref
Ting Wang, Suoli Han & Ge Du. (2021) S100A6 represses Calu‐6 lung cancer cells growth via inhibiting cell proliferation, migration, invasion and enhancing apoptosis . Cell Biochemistry and Function 39:6, pages 771-779.
Crossref
Dilip Kumar, Vijay Kushwaha & Umesh Yadava. (2021) Explorations on the electronic structure and spectroscopic IR assignments of 5-methyl-2-(2-oxopropyl)-pyrazolo[5,1-b]quinazolin-9(3H)-one molecule. IOP SciNotes 2:1, pages 014004.
Crossref
Gurmeet Kaur, James H. Doroshow & Beverly A. Teicher. (2021) Format (2D vs 3D) and media effect target expression and response of patient-derived and standard NSCLC lines to EGFR inhibitors. Cancer Treatment and Research Communications 29, pages 100463.
Crossref
Monira Hoque, Yasmin A. Elmaghrabi, Meryem Köse, Syed S. Beevi, Jaimy Jose, Elsa Meneses‐Salas, Patricia Blanco‐Muñoz, James R. W. Conway, Alexander Swarbrick, Paul Timpson, Francesc Tebar, Carlos Enrich, Carles Rentero & Thomas Grewal. (2020) Annexin A6 improves anti‐migratory and anti‐invasive properties of tyrosine kinase inhibitors in EGFR overexpressing human squamous epithelial cells. The FEBS Journal 287:14, pages 2961-2978.
Crossref
Kate R. Secombe, Ysabella Z. A. Van Sebille, Bronwen J. Mayo, Janet K. Coller, Rachel J. Gibson & Joanne M. Bowen. (2020) Diarrhea Induced by Small Molecule Tyrosine Kinase Inhibitors Compared With Chemotherapy: Potential Role of the Microbiome. Integrative Cancer Therapies 19, pages 153473542092849.
Crossref
Keshav Raj Paudel, Nisha Panth, Rudra Pangeni, Rajendra Awasthi, Viney Chawla, Meenu Mehta, Murtaza M. Tambuwala & Philip M. Hansbro. 2020. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems 493 516 .
Lei Han, Zhou-Xia Wei, Yu-Feng Lv & Ai-Ying Jiang. (2019) Efficacy of carboplatin plus S-1 for the treatment of non-small cell lung cancer. Medicine 98:14, pages e15099.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.